Paul Matteis

Stock Analyst at Stifel

(2.93)
# 2,629
Out of 5,182 analysts
131
Total ratings
43.18%
Success rate
0.17%
Average return

Stocks Rated by Paul Matteis

Definium Therapeutics
Apr 17, 2026
Initiates: Buy
Price Target: $30
Current: $20.98
Upside: +42.99%
Immunic
Apr 17, 2026
Initiates: Buy
Price Target: $25
Current: $9.98
Upside: +150.50%
LB Pharmaceuticals
Mar 27, 2026
Maintains: Buy
Price Target: $35$40
Current: $31.81
Upside: +25.75%
KalVista Pharmaceuticals
Mar 26, 2026
Maintains: Buy
Price Target: $39$42
Current: $19.16
Upside: +119.21%
Ionis Pharmaceuticals
Feb 26, 2026
Maintains: Hold
Price Target: $73$77
Current: $72.23
Upside: +6.60%
ACADIA Pharmaceuticals
Feb 26, 2026
Maintains: Hold
Price Target: $25$24
Current: $22.30
Upside: +7.62%
Vertex Pharmaceuticals
Feb 13, 2026
Maintains: Hold
Price Target: $445$466
Current: $426.01
Upside: +9.39%
uniQure
Dec 11, 2025
Maintains: Buy
Price Target: $50$40
Current: $17.90
Upside: +123.46%
Neurocrine Biosciences
Dec 11, 2025
Maintains: Buy
Price Target: $183$188
Current: $128.04
Upside: +46.83%
Dyne Therapeutics
Dec 11, 2025
Maintains: Buy
Price Target: $36$39
Current: $18.04
Upside: +116.19%
Maintains: Buy
Price Target: $495$508
Current: $308.51
Upside: +64.66%
Initiates: Buy
Price Target: $28
Current: $30.64
Upside: -8.62%
Maintains: Hold
Price Target: $2$3
Current: $2.22
Upside: +35.14%
Downgrades: Hold
Price Target: $73$61
Current: $53.81
Upside: +13.37%
Upgrades: Buy
Price Target: $144$202
Current: $180.67
Upside: +11.81%
Maintains: Buy
Price Target: $9$12
Current: $1.60
Upside: +650.00%
Maintains: Buy
Price Target: $78$94
Current: $85.20
Upside: +10.33%
Initiates: Buy
Price Target: $32
Current: $39.21
Upside: -18.39%
Maintains: Buy
Price Target: $18$32
Current: $19.60
Upside: +63.31%
Initiates: Buy
Price Target: $11
Current: $8.89
Upside: +23.73%
Downgrades: Hold
Price Target: $4
Current: $2.35
Upside: +70.21%
Maintains: Buy
Price Target: $32$10
Current: $24.27
Upside: -58.80%
Maintains: Buy
Price Target: $44$60
Current: $27.05
Upside: +121.81%
Upgrades: Buy
Price Target: $25$36
Current: $33.73
Upside: +6.73%
Initiates: Buy
Price Target: $35
Current: $35.40
Upside: -1.13%
Initiates: Buy
Price Target: $29
Current: $13.00
Upside: +123.08%
Initiates: Buy
Price Target: $20
Current: $5.63
Upside: +255.56%
Initiates: Buy
Price Target: $12
Current: $0.57
Upside: +2,000.47%
Initiates: Buy
Price Target: $27
Current: $2.52
Upside: +971.43%
Maintains: Outperform
Price Target: $53$64
Current: $6.94
Upside: +822.19%